Skip to main content

Table 1 Clinical echocardiographic parameters in KD and control

From: Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease

 

KD (acute)

KD (subacute)

KD (convalescence)

Healthy control

p

Left Ventricle

     

M-mode

     

 LV EDD (mm)

33.6 ± 3.4

32.9 ± 3.6

33.3 ± 3.2

32.7 ± 2.5

0.56

 LV ESD (mm)

17.1 ± 1.9

17.6 ± 1.4

16.9 ± 2.0

17.2 ± 1.7

0.32

 IVSd (mm)

4.2 ± 0.5

4.3 ± 0.3

4.1 ± 0.4

4.1 ± 0.3

0.38

 LV PWd (mm)

4.0 ± 0.4

4.1 ± 0.4

4.0 ± 0.5

4.1 ± 0.4

0.62

 LV mass (g)

22.9 ± 0.4

22.3 ± 0.5

22.8 ± 0.5

23.0 ± 0.4

0.33

 LV eject fraction (%)

68.3 ± 4.2

70.2 ± 6.1

69.5 ± 5.7

68.9 ± 5.5

0.14

Mitral inflow velocities

     

 E (cm/s)

97.7 ± 10.2

105.4 ± 9.7

93.8 ± 13.5

98.7 ± 12.5

0.49

 A (cm/s)

59.9 ± 12.5

57.5 ± 14.7

61.4 ± 13.2

62.3 ± 11.9

0.78

 E/A ratio

1.6 ± 0.4

1.8 ± 0.4

1.5 ± 0.3

1.6 ± 0.4

0.65

Right ventricle

     

Tricuspid inflow velocities

     

 E (cm/s)

71.0 ± 12.1

74.3 ± 10.5

69.8 ± 8.4

73.4 ± 15.1

0.84

 A (cm/s)

50.0 ± 6.9

54.9 ± 9.8

53.8 ± 7.3

51.5 ± 5.3

0.33

 E/A ratio

1.4 ± 0.3

1.4 ± 0.2

1.3 ± 0.2

1.4 ± 0.3

0.79

  1. Abbreviations: KD Kawasaki disease, LV left ventricle, EDD end-diastolic dimension, ESD end-systolic dimension, IVSd interventricular septal thickness at diastole, PWd posterior wall thickness at diastole